Amundi Boosts Stake in Phibro Animal Health Co. (NASDAQ:PAHC)

Amundi raised its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 185.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,855 shares of the company’s stock after acquiring an additional 6,403 shares during the period. Amundi’s holdings in Phibro Animal Health were worth $212,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Geode Capital Management LLC grew its position in Phibro Animal Health by 5.7% during the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock valued at $11,430,000 after acquiring an additional 27,201 shares during the period. Barclays PLC boosted its position in shares of Phibro Animal Health by 25.7% in the third quarter. Barclays PLC now owns 143,337 shares of the company’s stock worth $3,228,000 after buying an additional 29,271 shares during the period. Algert Global LLC boosted its position in shares of Phibro Animal Health by 521.1% in the third quarter. Algert Global LLC now owns 71,335 shares of the company’s stock worth $1,606,000 after buying an additional 59,850 shares during the period. FMR LLC boosted its position in shares of Phibro Animal Health by 22.7% in the third quarter. FMR LLC now owns 39,310 shares of the company’s stock worth $885,000 after buying an additional 7,270 shares during the period. Finally, BNP Paribas Financial Markets boosted its position in shares of Phibro Animal Health by 3.1% in the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock worth $548,000 after buying an additional 729 shares during the period. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Price Performance

Shares of NASDAQ:PAHC opened at $21.90 on Friday. Phibro Animal Health Co. has a one year low of $12.07 and a one year high of $26.55. The stock has a fifty day moving average of $22.68 and a 200-day moving average of $22.59. The company has a market capitalization of $887.02 million, a PE ratio of 45.63, a price-to-earnings-growth ratio of 0.45 and a beta of 0.58. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. As a group, equities analysts anticipate that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.

Phibro Animal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health’s dividend payout ratio is 100.00%.

Analyst Ratings Changes

Several brokerages have recently weighed in on PAHC. Barclays upped their target price on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research report on Monday, February 10th. Morgan Stanley upped their target price on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Tuesday, December 17th. Finally, StockNews.com raised Phibro Animal Health from a “hold” rating to a “buy” rating in a research report on Saturday, March 15th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $21.00.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.